Frazier Lifesciences Acquisition Corp (FLAC) Peer Comparison
$9.87
$0.18
(1.82%)
As on 22-Nov-2022 15:58EDT
Market cap
$175 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
65.8
P/B Ratio
1.4
Div. Yield
0 %
Edit
| Frazier Lifesciences Acquisition Corp (FLAC) | Global Partner Acquisition II Corp (GPAC) | |
|---|---|---|
Market cap ($ Mln) |
175 | 296 |
Revenue ($ Mln) |
-- | -- |
Net Profit ($ Mln) |
-3.64 | -7.35 |
Net Margin (%) |
-825.63 | -- |
RoE (%) |
-- | -- |
Price to Earnings |
65.80 | -- |
Price-To-Book |
1.38 | 4.18 |
Cashflow ($ Mln)
| Frazier Lifesciences Acquisition Corp (FLAC) | Global Partner Acquisition II Corp (GPAC) | |
|---|---|---|
|
Cash From Operating Activities
|
-0.14 | -1.04 |
|
Cash Flow from Investing Activities
|
-- | -300.00 |
|
Cash from Financing Activities
|
0.00 | 301.87 |
|
Net Cash Inflow / Outflow
|
-0.14 | 0.82 |
Ratios
Profitability Ratios
| Frazier Lifesciences Acquisition Corp (FLAC) | Global Partner Acquisition II Corp (GPAC) | |
|---|---|---|
|
ROCE (%)
|
3.14 | 3.42 |
|
ROE (%)
|
3.14 | 3.42 |
|
ROA (%)
|
-2.58 | 3.12 |
|
EBIT Margin (%)
|
-- | -- |
|
Net Margin (%)
|
-825.63 | 52.11 |
|
Cash Profit Margin (%)
|
-- | -- |
Growth Ratios
| Frazier Lifesciences Acquisition Corp (FLAC) | Global Partner Acquisition II Corp (GPAC) | |
|---|---|---|
|
Revenue Growth (%)
|
-- | -- |
|
EBIT Growth (%)
|
-242.73 | -- |
|
Net Profit Growth (%)
|
-2,154.38 | 15,783.33 |
|
EPS Growth (%)
|
-- | 157.83 |
|
Book Value Growth (%)
|
-- | -- |
Valuation Ratios
| Frazier Lifesciences Acquisition Corp (FLAC) | Global Partner Acquisition II Corp (GPAC) | |
|---|---|---|
|
Price / Earnings
|
-- | 77.31 |
|
Price / Book Value
|
-- | 1.32 |
|
Dividend Yield (%)
|
-- | -- |
|
EV/EBITDA
|
0.18 | 83,276.49 |
|
Market Cap ($ Cr)
|
-- | -- |
Solvency Ratios
| Frazier Lifesciences Acquisition Corp (FLAC) | Global Partner Acquisition II Corp (GPAC) | |
|---|---|---|
|
Debt to Equity
|
0.00 | 9.95 |
|
Short term debt to equity ratio
|
0.00 | 9.95 |
|
Current Ratio
|
0.12 | 0.37 |
|
Quick Ratio
|
0.12 | -- |
|
Interest Coverage
|
-225.90 | -0.21 |
Operating Efficiency Ratios
| Frazier Lifesciences Acquisition Corp (FLAC) | Global Partner Acquisition II Corp (GPAC) | |
|---|---|---|
|
Debtors to sales (%)
|
-- | -- |
|
Asset Turnover
|
0.00 | 0.00 |
|
Receivable days
|
-- | -- |
|
Inventory Days
|
-- | -- |
|
Payable days
|
-- | -- |
|
Cash Conversion Cycle
|
-- | -- |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
